Volume and energy folding landscape of prion protein revealed by pressure

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 8, 2005, Pages 1195-1201

  Cordeiro, Y ^a   Kraineva, J ^b   Winter, R ^b   Silva, Jerson L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Aggregation; High pressure; Prion; Structural conversion

Indexed keywords

CELL PROTEIN; ISOPROTEIN; PRION PROTEIN;

BETA SHEET; ENERGY TRANSFER; HYDROSTATIC PRESSURE; HYPOTHESIS; NONHUMAN; PRION; PRION DISEASE; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW; SCRAPIE; VIRUS INFECTIVITY; VOLUMETRY;

SCRAPIE PRION;

EID: 23844540599     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000800006     Document Type: Review

References (60)

1. Prusiner SB (1982). Novel proteinaceous infectious particles cause scrapie. Science, 216: 136-144.
2. Prusiner SB (1998). Prions. Proceedings of the National Academy of Sciences, USA, 95: 13363-13383.
3. Weissmann C (1999). Molecular genetics of transmissible spongiform encephalopathies. Journal of Biological Chemistry, 274: 3-6.
4. Caughey B (2001). Interactions between prion protein isoforms: the kiss of death? Trends in Biochemical Sciences, 26: 235-242.
5. Aguzzi A & Polymenidou M (2004). Mammalian prion biology: one century of evolving concepts. Cell, 116: 313-327.
6. Pan KM, Baldwin M, Nguyen J et al. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, USA, 90: 10962-10966.
7. Caughey BW, Dong A, Bhat KS et al. (1991). Secondary structure analysis of the scrapie-associated protein PrP27-30 in water by infrared spectroscopy. Biochemistry, 30: 7672-7680.
8. Caughey B, Raymond GJ, Ernst D et al. (1991). N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. Journal of Virology, 65: 6597-6603.
9. Snow AD, Wight TN, Nochlin D et al. (1990). Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Sträussler syndrome, Creutzfeldt-Jakob disease and scrapie. Laboratory Investigation, 63: 601-611.
10. Caughey B & Raymond GJ (1993). Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. Journal of Virology, 67: 643-650.
11. Gabizon R, Meiner Z, Halimi M et al. (1993). Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. Journal of Cell Physiology, 157: 319-325.
12. Sc-dependent cell-free formation of protease-resistant prion protein. EMBO Journal, 20: 377-386.
13. Telling GC, Scott M, Mastrianni J et al. (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell, 83: 79-90.
14. Kaneko K, Zulianello L, Scott M et al. (1997). Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proceedings of the National Academy of Sciences, USA, 94: 10069-10074.
15. Cordeiro Y, Machado F, Juliano L et al. (2001). DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. Journal of Biological Chemistry, 276: 49400-49409.
16. Deleault NR, Lucassen RW & Supattapone S (2003). RNA molecules stimulate prion protein conversion. Nature, 425: 717-720.
17. Caughey B & Kocisko DA (2003). Prion diseases: a nucleic-acid accomplice? Nature, 425: 673-674.
18. Cordeiro Y, Lima LMTR, Gomes MP et al. (2004). Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4′-dianilino-1,1′-binaphthyl-5,5′-sulfonate (bis-ANS). Journal of Biological Chemistry, 279: 5346-5352.
19. Nandi PK & Nicole JC (2004). Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent. Journal of Molecular Biology, 344: 827-837.
20. Safar J, Roller PP, Gajdusek DC et al. (1993). Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Science, 2: 2206-2216.
21. Swietnicki W, Petersen R, Gambetti P et al. (1997). pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). Journal of Biological Chemistry, 272: 27517-27520.
22. Riek R, Wider G, Billeter M et al. (1998). Prion protein NMR structure and familial human spongiform encephalopathies. Proceedings of the National Academy of Sciences, USA, 95: 11667-11672.
23. Cohen FE (1999). Protein misfolding and prion diseases. Journal of Molecular Biology, 293: 313-320.
24. Swietnicki W, Morillas M, Chen SG et al. (2000). Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry, 39: 424-431.
25. Baskakov IV, Legname G, Prusiner SB et al. (2001). Folding of prion protein to its native alpha-helical conformation is under kinetic control. Journal of Biological Chemistry, 276: 19687-19690.
26. Baskakov IV, Legname G, Baldwin MA et al. (2002). Pathway complexity of prion protein assembly into amyloid. Journal of Biological Chemistry, 277: 21140-21148.
27. Baskakov IV, Legname G, Gryczynski Z et al. (2004). The peculiar nature of unfolding of the human prion protein. Protein Science, 13: 586-595.
28. Zhou JM, Zhu L, Balny C et al. (2001). Pressure denaturation of the yeast prion protein Ure2. Biochemical and Biophysical Research Communications, 287: 147-152.
29. Kuwata K, Li H, Yamada H et al. (2002). Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? Biochemistry, 41: 12277-12283.
30. Cordeiro Y, Kraineva J, Ravindra R et al. (2004). Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies. Journal of Biological Chemistry, 279: 32354-32359.
31. Kuwata K, Kamatari YO, Akasaka K et al. (2004). Slow conformational dynamics in the hamster prion protein. Biochemistry, 43: 4439-4446.
32. Torrent J, Alvarez-Martinez MT, Harricane MC et al. (2004). High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation. Biochemistry, 43: 7162-7170.
33. Taylor DM & Fernie K (1996). Exposure to autoclaving or sodium hydroxide extends the dose-response curve of the 263K strain of scrapie agent in hamsters. Journal of General Virology, 77: 811-813.
34. Schreuder BE, Geertsma RE, van Keulen LJ et al. (1998). Studies on the efficacy of hyperbaric rendering procedures in inactivating bovine spongiform encephalopathy (BSE) and scrapie agents. Veterinary Research, 142: 474-480.
35. Silva JL, Foguel D & Royer C (2001). Pressure provides new insights into protein folding, dynamics and structure. Trends in Biochemical Sciences, 26: 612-618.
36. Royer CA (2002). Revisiting volume changes in pressure-induced protein unfolding. Biochimica et Biophysica Acta, 25: 201-209.
37. Mozhaev VV, Heremans K, Frank J et al. (1996). High pressure effects on protein structure and function. Proteins, 24: 81-91.
38. Foguel D, Suarez MC, Ferrão-Gonzales AD et al. (2003). Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities. Proceedings of the National Academy of Sciences, USA, 100: 9831-9836.
39. Foguel D & Silva JL (2004). New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies. Biochemistry, 43: 11361-11370.
40. Weber G & Drickamer HG (1983). The effect of high pressure upon proteins and other biomolecules. Quarterly Reviews of Biophysics, 16: 89-112.
41. Silva JL, Foguel D, Suarez M et al. (2004). High-pressure applications in medicine and pharmacology. Journal of Physics: Condensed Matter, 16: S929-S944.
42. Jonas J & Jonas A (1994). High-pressure NMR spectroscopy of proteins and membranes. Annual Review of Biophysics and Biomolecular Structure, 23: 287-318.
43. Akasaka K, Tezuka T & Yamada H (1997). Pressure-induced changes in the folded structure of lysozyme. Journal of Molecular Biology, 271: 671-678.
44. Ferrão-Gonzales AD, Souto SO, Silva JL et al. (2000). The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proceedings of the National Academy of Sciences, USA, 97: 6445-6450.
45. Torrent J, Alvarez-Martinez MT, Heitz F et al. (2003). Alternative prion structural changes revealed by high pressure. Biochemistry, 42: 1318-1325.
46. Ishimaru D, Andrade LR, Teixeira LS et al. (2003). Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry, 42: 9022-9027.
47. Brown P, Meyer R, Cardone F et al. (2003). Ultra-high-pressure inactivation of prion infectivity in processed meat: a practical method to prevent human infection. Proceedings of the National Academy of Sciences, USA, 100: 6093-6097.
48. Fernandez-Garcia A, Heindl P, Voigt H et al. (2004). Reduced proteinase K resistance and infectivity of prions after pressure treatment at 60 degrees C. Journal of General Virology, 85: 261-264.
49. Garcia AF, Heindl P, Voigt H et al. (2005). Dual nature of the infectious prion protein revealed by high pressure. Journal of Biological Chemistry, 280: 9842-9847.
50. Perrett S, Freeman SJ, Butler PJ et al. (1999). Equilibrium folding properties of the yeast prion protein determinant Ure2. Journal of Molecular Biology, 290: 331-345.
51. Perrett S & Zhou JM (2002). Expanding the pressure technique: insights into protein folding from combined use of pressure and chemical denaturants. Biochimica et Biophysica Acta, 1595: 210-223.
52. Apetri AC & Surewicz WK (2003). Atypical effect of salts on the thermodynamic stability of human prion protein. Journal of Biological Chemistry, 278: 22187-22192.
53. Byler DM & Susi H (1986). Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers, 25: 469-487.
54. Panick G, Malessa R & Winter R (1999) Differences between the pressure- and temperature-induced denaturation and aggregation of beta-lactoglobulin A, B, and AB monitored by FT-IR spectroscopy and small-angle X-ray scattering. Biochemistry, 38: 6512-6519.
55. Dzwolak W, Ravindra R, Lendermann J et al. (2003). Aggregation of bovine insulin probed by DSC/PPC calorimetry and FTIR spectroscopy. Biochemistry, 42: 11347-11355.
56. Herberhold H, Marchal S, Lange R et al. (2003). Characterization of the pressure-induced intermediate and unfolded state of red-shifted green fluorescent protein - a static and kinetic FTIR, UV/VIS and fluorescence spectroscopy study. Journal of Molecular Biology, 330: 1153-1164.
57. Kocisko DA, Come JH, Priola SA et al. (1994). Cell-free formation of protease-resistant prion protein. Nature, 370: 471-474.
58. Apetri AC, Surewicz KA & Surewicz WK (2004). The effect of disease-associated mutations on the folding pathway of human prion protein. Journal of Biological Chemistry, 279: 18008-18014.
59. Martins SM, Chapeaurouge A & Ferreira ST (2003). Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature. Journal of Biological Chemistry, 278: 50449-50455.
60. Silva JL & Weber G (1993). Pressure stability of proteins. Annual Review of Physical Chemistry 44: 89-113.